Skip to content

Liver Fibrosis Evaluation Using Ultrasound Shear Wave Imaging

Liver Fibrosis Evaluation Using Ultrasound Shear Wave Imaging

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03637959
Enrollment
270
Registered
2018-08-20
Start date
2017-01-26
Completion date
2020-11-04
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Fibrosis

Brief summary

The Researchers are trying to assess the effectiveness of a new ultrasound technique for non-invasive evaluation of liver fibrosis.

Detailed description

Utilizing vibrating transducer, receiver and speaker in differing sequences, while collecting ultrasound liver tissue elastography measurements during participant breath holds. Participants fast for a minimum of four hours and are positioned lying on left side with knees slightly bent.

Interventions

DEVICEMechanical Vibrations with Ultrasound Shear Wave Imaging

Multiple miniature mechanical vibrators will be placed on the body surface of rib cage of the subject or introduced through an audio loudspeaker in contact with the subject's upper torso or through miniature vibrator attached to the ultrasound probe. Repeated ultrasound stiffness measurements will be made at different locations within the liver parenchyma while the mini vibrators introduce shear wave in the liver, similar to an MRE examination.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers or patients who are scheduled for clinically indicated liver MRE for fibrosis staging. * Age 18 to 80.

Exclusion criteria

* Subjects lacking capacity to consent * Subjects with unreliable ultrasound or MRE measurements. * Pregnant women.

Design outcomes

Primary

MeasureTime frameDescription
Liver Stiffness Measured by MREBaseline, approximately 1 dayLiver stiffness measured by standard of care Magnetic Resonance Elastography reported in Kilopascals (kPa) (used as a benchmark reference in this study).
Liver Stiffness Measured by Mechanical Vibrations With Ultrasound Shear Wave ImagingBaseline, approximately 1 dayLiver stiffness measured by Mechanical Vibrations with Ultrasound Shear Wave Imaging reported in kilopascal (kPa).

Countries

United States

Participant flow

Participants by arm

ArmCount
Mechanical Vibrations With Ultrasound Shear Wave Imaging
Subjects that are scheduled to undergo a clinical indicated Magnetic Resonance Elastography (MRE) will also have mechanical vibrations ultrasound shear wave imaging to measure liver stiffness Mechanical Vibrations with Ultrasound Shear Wave Imaging: Multiple miniature mechanical vibrators will be placed on the body surface of rib cage of the subject or introduced through an audio loudspeaker in contact with the subject's upper torso or through miniature vibrator attached to the ultrasound probe. Repeated ultrasound stiffness measurements will be made at different locations within the liver parenchyma while the mini vibrators introduce shear wave in the liver, similar to an MRE examination.
270
Total270

Baseline characteristics

CharacteristicMechanical Vibrations With Ultrasound Shear Wave Imaging
Age, Continuous52.1 years
STANDARD_DEVIATION 15.4
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
256 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
8 Participants
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants
Race (NIH/OMB)
Asian
6 Participants
Race (NIH/OMB)
Black or African American
4 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
8 Participants
Race (NIH/OMB)
White
250 Participants
Region of Enrollment
United States
270 participants
Sex: Female, Male
Female
130 Participants
Sex: Female, Male
Male
140 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 270
other
Total, other adverse events
0 / 270
serious
Total, serious adverse events
0 / 270

Outcome results

Primary

Liver Stiffness Measured by Mechanical Vibrations With Ultrasound Shear Wave Imaging

Liver stiffness measured by Mechanical Vibrations with Ultrasound Shear Wave Imaging reported in kilopascal (kPa).

Time frame: Baseline, approximately 1 day

ArmMeasureValue (MEAN)Dispersion
Mechanical Vibrations With Ultrasound Shear Wave ImagingLiver Stiffness Measured by Mechanical Vibrations With Ultrasound Shear Wave Imaging2.66 kPaStandard Deviation 1
Primary

Liver Stiffness Measured by MRE

Liver stiffness measured by standard of care Magnetic Resonance Elastography reported in Kilopascals (kPa) (used as a benchmark reference in this study).

Time frame: Baseline, approximately 1 day

ArmMeasureValue (MEAN)Dispersion
Mechanical Vibrations With Ultrasound Shear Wave ImagingLiver Stiffness Measured by MRE3.07 kPaStandard Deviation 1.36

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026